IOL Chemicals And Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 524164 | NSE: IOLCP | Pharmaceuticals & Drugs | Small Cap

IOL Chem & Pharma Share Price

399.05 4.00 1.01%
as on 12-Apr'24 16:59

DeciZen - make an informed investing decision on IOL Chem & Pharma

Overall Rating
Bole Toh

1. Quality

2. Valuation


3. Price Trend

Semi Strong

IOL Chemicals And Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (CD):
Market Cap:
2,342.6 Cr.
52-wk low:
52-wk high:

Is IOL Chemicals And Pharmaceuticals Ltd an attractive stock to invest in?

1. Is IOL Chemicals And Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that IOL Chemicals And Pharmaceuticals Ltd is a below average quality company.

2. Is IOL Chemicals And Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of IOL Chemicals And Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is IOL Chemicals And Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of IOL Chemicals And Pharmaceuticals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of IOL Chem & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
IOL Chemicals And Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 0%0%0%0%0%0%0%0%11.6%9.7%-
Value Creation

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000000002,1842,2172,216
Adj EPS 0000000027.522.929.2
BVPS (₹) 00000000237.2256.8274.7
Adj Net
Cash Flow from Ops. 0000000093.1122-
Debt/CF from Ops. 000000000.50.7-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA1.5%
Adj EPS NANANA-16.5%
Share Price 34.2% 15.6% -12.1% 11.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on
Equity %
Op. Profit
Mgn %
Net Profit
Mgn %
Debt to
Working Cap
Cash Conv.

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 11.00%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.60%

Latest Financials - IOL Chemicals And Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 29.4 29.2
TTM Sales (₹ Cr.) 2,216 2,216
BVPS (₹.) 274.6 274.7
Reserves (₹ Cr.) 1,553 1,554
P/BV 1.45 1.45
PE 13.58 13.65
From the Market
52 Week Low / High (₹) 344.35 / 535.60
All Time Low / High (₹) 0.33 / 898.40
Market Cap (₹ Cr.) 2,343
Equity (₹ Cr.) 58.7
Face Value (₹) 10
Industry PE 48

Management X-Ray of IOL Chem & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of IOL Chem & Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
Operating Expenses 1,9261,991
Manufacturing Costs115175
Material Costs1,5711,547
Employee Cost 141168
Other Costs 99101
Operating Profit 258226
Operating Profit Margin (%) 11.8%10.2%
Other Income 3226
Interest 816
Depreciation 4346
Exceptional Items -140
Profit Before Tax 225189
Tax 5750
Profit After Tax 168139
PAT Margin (%) 7.7%6.3%
Adjusted EPS (₹)28.623.7
Dividend Payout Ratio (%)14%17%

Balance Sheet

(All Figures are in Crores.)

Equity and Liabilities

Shareholders Fund 1,3921,508
Share Capital 5959
Reserves 1,3341,449
Minority Interest00
Long Term Debt00
Short Term Debt4380
Trade Payables409314
Others Liabilities 180167
Total Liabilities 2,0242,068

Fixed Assets

Gross Block762995
Accumulated Depreciation201243
Net Fixed Assets561752
CWIP 10590
Investments 220
Trade Receivables470505
Cash Equivalents 14022
Others Assets336354
Total Assets 2,0242,068

Cash Flow

(All Figures are in Crores.)
Cash Flow From Operating Activity 93122
PBT 225189
Adjustment 3344
Changes in Working Capital -102-64
Tax Paid -63-47
Cash Flow From Investing Activity -121-120
Capex -151-210
Net Investments 2280
Others 89
Cash Flow From Financing Activity -2-4
Net Proceeds from Shares 00
Net Proceeds from Borrowing 00
Interest Paid -8-16
Dividend Paid -35-24
Others 4236
Net Cash Flow -29-2
ROE (%)12.049.6
ROCE (%)16.2513.57
Asset Turnover Ratio1.081.08
PAT to CFO Conversion(x)0.550.88
Working Capital Days
Receivable Days7980
Inventory Days6961
Payable Days9585

IOL Chemicals And Pharmaceuticals Ltd Stock News

IOL Chemicals And Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of IOL Chem & Pharma on 12-Apr-2024 16:59 is ₹399.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Apr-2024 16:59 the market cap of IOL Chem & Pharma stood at ₹2,342.6.
The latest P/E ratio of IOL Chem & Pharma as of 12-Apr-2024 16:59 is 13.58.
The latest P/B ratio of IOL Chem & Pharma as of 12-Apr-2024 16:59 is 1.45.
The 52-week high of IOL Chem & Pharma is ₹535.6 and the 52-week low is ₹344.4.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of IOL Chem & Pharma is ₹2,216 ( Cr.) .

About IOL Chemicals And Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike.

IOLCP has attained a front line position in the domestic segment and is thus contemplating to widen its horizon through global penetration. It has overseas customers from various countries like Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt and many others.

IOLCP is therefore moving ahead with its vision to develop global strategic alliances with quality leaders and expand into new markets.

Product range of the company includes:

  • Acetic AcidWith a production capacity of 6.5 million metric tonnes, Acetic Acid is a significant chemical reagent & industrial chemical with a wide spectrum of applications.
  • Ethyl Acetate Ethyl Acetate is a significant industrial solvent with diverse industrial applications.
  • Acetic AnhydrideAcetic Anhydride is a well-known acid anhydride that is widely used in pharmaceutical & agrochemical industries.
  • Isobutyl BenzeneThis specialty chemical is used as an intermediate in Ibuprofen and other anti-inflammatory analgesic bulk drug
  • Mono Chloro Acetic AcidAlso know as Chloro Acetic Acid it is used in agrochemicals, pesticides, insecticides, organic chemicals etc.
  • Acetyl ChlorideAcetyl Chlorideis is colourless, near to pale yellow liquid that is used in perfume, dye, chemical, pharmaceutical bulk drugs and intermediates.
  • Ibuprofen A non-steroidal anti-inflammatory drug, Ibuprofen is used in the treatment of a variety of ailments such as arthritis, dysmenorrhoea, and is also used an analgesic.  


They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, CIPLA, Flex Industries, ICI Paints, Asian Paints, Pidilite, Rallis India, Hindustan Polymide, Gujarat Super Phosphate, & Avon Organics etc.

Awards & Achievements:

  • IOL Chemicals & Pharmaceuticals has consecutively been bestowed with the 2nd Prize in Chemical Sector-National Energy Conservation Award 2007, by the Ministry of Power, Government of India for the third time in a row for its efforts made towards new technology implementation to conserve the energy resources of the company.
  • IOLCP has also won Kamla Dial Gold Standard for North-West Qual Tech Standards-2006 conducted by Qimpro College Mumbai.
  • One star Export House Status Award.
  • National Energy Conservation Award 2007.
  • National Energy Conservation Award 2006.
  • National Energy Conservation Award 2005.
  • One star export House Status Award.
  • Halal Certification.
  • Kosher Certification.
  • USFDA Certification.
  • EDQM Certification.

Future Plans:

  • Chemicals Expansion - The company has planned for increasing the capacity of Acetic Acid from 50000 TPA to 66000 TPA, Ethyl Acetate from 33000 TPA to 36000 TPA & Capacity of Acetic Anhydride from 12000 TPA to 18000 TPA.
  • Pharma Expansion -  IOLCP recently boosted its Ibuprofen plant capacity to 3600 TPA from 1800 TPA and to further expand the capacity to 6000 TPA.
  • PPI's - The company has planned for installation of new manufacturing facilities of following PPIs:-Rabeprazole -Lansoprazole -Omeprazole -Pantoprazole -Esomeprazole. With annual installed capacity of 360 MT, the commercial production will start by the end of 2008.
  • Co-generation Power Plant  - To meet out its enhanced energy requirement and to become self reliance the company has also proposed for another captive co-generation plant with additional capacity of 13 MW in addition to the existing cogeneration plant of 4 MW capacity.
  • Forward Integration - The company has planned for adding two more products i.e. Mono Chloro Acetic Acid(MCA) with a capacity of 6600 TPA & Acetyl Chloride with a capacity of 4800 TPA , using Acetic Anhydride & Acetic Acid as a raw material.
  • Backward Integration - The company has planned for setting up plant for Iso-butyl Benzene(IBB) with a capacity of 6000 TPA which will be the raw material for the manufacturing of Ibuprofen.
  • Research & Development  - To develop new Molecules and process development
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.